Skip to content
Monday 17 August 2026London --:--Frankfurt --:--Zurich --:--
NewslettersSearchEN · DE · FR
MorningWire

European business, markets and politics

FTSE 100
10,720.30
-0.28%
DAX
26,338.61
-0.38%
CAC 40
8,579.60
-0.66%
STOXX 50
6,530.45
-0.14%
  • Europe
  • Markets
  • Business
  • Economy
  • Regulation
  • Politics
  • Opinion
More
GermanyFranceEU InstitutionsCompetitionPublic AffairsBankingTechnologyEnergy
  • Germany
  • France
  • Europe
  • Markets
  • Business
  • Economy
  • Regulation
  • Politics
  • Opinion
  • DE
Thursday 04 February 2021 9:08 am

More than 1m Londoners have received first dose of Covid vaccine

By: Poppy Wood

Add as a preferred source on Google
London Will Move To Tier 2 Coronavirus Restrictions On Saturday
The NHS had originally set a target of 14 February to have vaccinated 1m Londoners

More than 1m people in London have received their first dose of the coronavirus vaccine, following concerns that the capital had been falling behind in the nation’s immunisation programme.

Official figures published last night showed 1,011,490 Londoners have received their first dose of either the Astrazeneca/Oxford University or Pfizer/Biontech vaccines, while a further 60,658 people have received a second dose of the jab.

The milestone comes just eight weeks after 90-year-old George Dyer became the first person in London to receive a Covid-19 vaccination at Croydon Hospital, and on the same day the UK passed the major landmark of administering 10m doses of the vaccine.

Ministers ramped up the vaccine rollout over the weekend, with a further 108,000 doses administered in the capital tipping London past official targets.

It places the NHS ahead of government targets to have offered a first dose to the four highest priority groups by 14 February, in a move that is expected to reduce deaths and illness caused by the  coronavirus by 65 per cent.

Mayor of London Sadiq Khan said: “It is truly fantastic news that more than one million doses of Covid-19 vaccine have been administered in London. This has been an incredibly difficult and challenging time for our city, but the vaccine is the light at the end of a dark tunnel. 

“This major milestone is down to the heroic work and dedication of our NHS staff, volunteers and venues who have gone above and beyond to deliver these life-saving vaccinations.”

Read more

Alkermes’ Alixorexton Demonstrated Sustained Improvement in Wakefulness in Adults With Narcolepsy Type 1 and Type 2 in Long-Term Extension Study Interim Analysis

However, the milestone follows weeks of wrangling from Khan over concerns the capital was falling behind in the vaccine race.

The mayor wrote an urgent letter to vaccines tsar Nadhim Zahawi just two weeks ago calling on him to scale up vaccine supply to meet different population densities.

Khan said he was “hugely concerned” that Londoners have received only a tenth of the vaccines that have been given across the country, when the capital’s population makes up close to 14 per cent of the country.

“The situation in London is critical with rates of the virus extremely high, which is why it’s so important that vulnerable Londoners are given access to the vaccine as soon as possible,” he added.

London has received the second-lowest number of vaccine doses in England, after weeks of trailing at the bottom of the list. The capital is ahead of the South West of the country, and just behind the East of England, where the Kent Covid variant is most rampant.

The NHS opened four major new vaccination centres in London last month as part of plans to scale up the capital’s vaccine programme. The sites include a large-scale vaccination centre at the Francis Crick Institute in central London and pop-up sites at a former Ikea store in Westfield Stratford, the Hornsey Central Neighbourhood Health Centre in Crouch End and at the Hawks Road Health Clinic in Kingston.

Read more

Cycle Pharmaceuticals Selects Forma Life Sciences to Establish U.S. Commercial Supply for FDA-Approved CAVHANZA™ (nilotinib) Orally Disintegrating Tablets

Share this article

  • Facebook
  • X
  • LinkedIn
  • WhatsApp
  • Email

Similarly tagged content:

Sections

  • News

Categories

  • Business
  • Tech

Related Topics

  • Coronavirus
  • Re-lockdown
  • Vaccine

Trending Articles

  • Nanochon Receives Regulatory Approval from Panamá’s Ministry of Health to Initiate First-in-Human Clinical Study of Chondrograft™

  • Analysis: What would Todd Boehly and Mark Walter stake sales mean for Chelsea?

  • We take a food and drink Odyssey through the Square Mile

  • Paramount-Warner Bros deal faces ‘sufficient competition’, says CMA

  • Watchdog takes aim at lawyers blaming juniors for AI blunders

More from Morning Wire

  • Alkermes’ Alixorexton Demonstrated Sustained Improvement in Wakefulness in Adults With Narcolepsy Type 1 and Type 2 in Long-Term Extension Study Interim Analysis

    Business Wire
  • Cycle Pharmaceuticals Selects Forma Life Sciences to Establish U.S. Commercial Supply for FDA-Approved CAVHANZA™ (nilotinib) Orally Disintegrating Tablets

    Business Wire
  • Lamborghini Urus SE Performante is an even more super SUV

    Life&Style
    Lamborghini Urus luxury SUV in motion, showcasing sleek design and performance on a scenic road for a news feature
  • Cabenuva demonstrates superiority to daily oral therapy in adolescents living with HIV, as ViiV Healthcare highlights new long-acting injectable data at AIDS 2026

    Business Wire
  • Sushidog investor pumps seven-figure sum into golf sim brand ahead of Open

    Sport Business
    TeeGo 27 electric scooter launch featuring sleek design and advanced technology in a modern urban setting
  • As it happened: Stocks slide despite tech and data boost; Oil falls after OPEC+ ups output

    Markets
    Samsung has missed earnings expectations
  • ILiAD Biotechnologies Expands Board of Directors and Appoints Chief Business Officer

    Business Wire
  • Silence Therapeutics Announces Positive Topline Results from Phase 2 SANRECO Trial of Divesiran in Polycythemia Vera, Supporting its Potential Best-in-Class Profile

    Business Wire
MorningWire

Independent European business, markets and political news for decision-makers.

Morning Briefing

Europe

  • Germany
  • France
  • EU Institutions
  • Europe

Business

  • Markets
  • Business
  • Economy
  • Regulation
  • Competition
  • Public Affairs

Editorial

  • Opinion
  • Editorial Policy
  • Corrections
  • Contact

Company

  • About Morning Wire
  • Privacy Policy
  • Terms of Use
  • Cookie Policy
© 2026 Morning Wire Ltd · Published by Morning Wire Media, Bahnhofstrasse 65, 8001 Zürich, Switzerland
Privacy · Terms · Cookies · Facebook